The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Blockade of Tim‐3 signaling restores the virus‐specific CD 8+T‐cell response in patients with chronic hepatitis B
Abstract
Chronic hepatitis B (CHB) is characterized by functionally impaired virus‐specific CD 8+ T‐cell responses. However, the mechanism underlying this dysfunction has not been fully clarified. We examined the role of a newly identified protein, T‐cell immunoglobulin domain and mucin domain‐containing molecule‐3 (T im‐3), in regulating the antiviral CD 8+ T‐cell response in CHB patients. T im‐3 expression on peripheral virus‐specific CD 8+ T cells from 20 CHB patients and 20 healthy controls was determined by flow cytometry. The phenotypes and cytokine‐producing capacity were compared between T im‐3+CD 8+ and T im‐3−CD 8+ T cells. The impact of T im‐3 signaling on cellular proliferation and cytokine‐producing capacity was also studied. T im‐3 expression on hepatitis B virus (HBV)‐specific CD 8+ T cells was higher than expression on cytomegalovirus (CMV)‐specific CD 8+ T cells. T im‐3+ CD 8+ T cells exhibited proliferative senescence phenotypes and decreased cytokine production upon antigen challenge. Finally, blocking the T im‐3 pathway significantly improved proliferation and antiviral cytokine secretion of CD 8+ T cells in response to HBV‐specific antigen peptides. T im‐3 negatively regulates antiviral responses of CD 8+ T cells isolated from CHB patients, and this response is reversed by blocking the T im‐3 pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
Cited by
Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation
Anderson, A. C., Joller, N., & Kuchroo, V. K. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.001 · Cited by 2,096
Tim‐3 and its role in regulating anti‐tumor immunity
Das, M., Zhu, C., & Kuchroo, V. K. (2017) · Immunological Reviews · doi:10.1111/imr.12520 · Cited by 856
Therapeutic strategies for hepatitis B virus infection: towards a cure
Fanning, G. C., Zoulim, F., Hou, J., & Bertoletti, A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0037-0 · Cited by 557
Immunotherapy: Reshape the Tumor Immune Microenvironment
LV, B., Wang, Y., Ma, D., Cheng, W., Liu, J., Yong, T., Chen, H., & Wang, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.844142 · Cited by 482
NK Cell-Based Immune Checkpoint Inhibition
Khan, M., Arooj, S., & Wang, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00167 · Cited by 356
Metadata
- Authors
- Wu, W., Shi, Y., Li, S., Zhang, Y., Liu, Y., Wu, Y., & Chen, Z.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2012-04-26
- Volume
- 42
- Issue
- 5
- Pages
- 1180-1191
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1543067125
- Cited by
- 158
- References
- 1
- FWCI
- 9.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blockade of Tim‐3 signaling restores the virus‐specific CD 8+T‐cell response in patients with chronic hepatitis B. https://app.cochat.ai/papers/10.1002/eji.201141852
- The paper
- Wu, W., Shi, Y., Li, S., Zhang, Y., Liu, Y., Wu, Y., & Chen, Z. (2012). Blockade of Tim‐3 signaling restores the virus‐specific CD 8+T‐cell response in patients with chronic hepatitis B. European Journal of Immunology. https://doi.org/10.1002/eji.201141852
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.